Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate ...

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...

Oct. 21, 2025 – A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to unprecedented results of a drug treatment trial in men whose ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

Using advanced computational genomics, Johns Hopkins investigators discovered how prostate cancer develops resistance to ...

Many commonly prescribed drugs have surprising other uses. Sept. 28, 2010 -- Viagra is well recognized for its primary use. But who knew it would show promise as a cancer fighter, too? Medical ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...

UNIVERSITY PARK, Pa. — Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by ...

Researchers have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs, solving a ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...